114 related articles for article (PubMed ID: 16162359)
1. Low p53 expression of acute myelocytic leukemia cells with t(8;21) chromosome abnormality: association with low p14(ARF) expression.
Shikami M; Miwa H; Nishii K; Kyo T; Tanaka I; Shiku H; Kita K; Nitta M
Leuk Res; 2006 Apr; 30(4):379-83. PubMed ID: 16162359
[TBL] [Abstract][Full Text] [Related]
2. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
[TBL] [Abstract][Full Text] [Related]
3. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
Kasashima K; Sakota E; Kozu T
Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
[TBL] [Abstract][Full Text] [Related]
4. p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.
Magro PG; Russo AJ; Li WW; Banerjee D; Bertino JR
Cancer Res; 2004 Jun; 64(12):4338-45. PubMed ID: 15205349
[TBL] [Abstract][Full Text] [Related]
5. [Acute myelogenous leukemia with ins(21;8) expressing AML-1-MTG8 fusion transcript].
Kazama H; Aoyama M; Sameshima Y; Teramura M; Masuda M; Motoji T; Okada M; Mizoguchi H
Rinsho Ketsueki; 1996 Nov; 37(11):1297-302. PubMed ID: 8960665
[TBL] [Abstract][Full Text] [Related]
6. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D
Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
[TBL] [Abstract][Full Text] [Related]
8. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.
Wang YY; Zhou GB; Yin T; Chen B; Shi JY; Liang WX; Jin XL; You JH; Yang G; Shen ZX; Chen J; Xiong SM; Chen GQ; Xu F; Liu YW; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1104-9. PubMed ID: 15650049
[TBL] [Abstract][Full Text] [Related]
9. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ
J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor suppression by a p14ARF/p53 bicistronic adenovirus through increased p53 protein translation and stability.
Huang Y; Tyler T; Saadatmandi N; Lee C; Borgstrom P; Gjerset RA
Cancer Res; 2003 Jul; 63(13):3646-53. PubMed ID: 12839954
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.
Yang G; Khalaf W; van de Locht L; Jansen JH; van der Reijden BA; Müller-Tidow C; Delwel HR; Serve H; Clapp DW; Hiebert SW
Ann Hematol; 2004 Jun; 83(6):329-30. PubMed ID: 15052372
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.
Yang G; Khalaf W; van de Locht L; Jansen JH; van der Reijden BA; Müller-Tidow C; Delwel HR; Serve H; Clapp DW; Hiebert SW
Ann Hematol; 2004; 83 Suppl 1():S83. PubMed ID: 15124686
[TBL] [Abstract][Full Text] [Related]
13. [Acute myelocytic leukemia with ins(21;8)(q22;q13q22) presenting with AML1/MTG8 chimeric mRNA].
Yamazaki E; Ogawa K; Harano H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2000 Sep; 41(9):745-9. PubMed ID: 11070937
[TBL] [Abstract][Full Text] [Related]
14. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L
J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194
[TBL] [Abstract][Full Text] [Related]
15. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K
Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713
[TBL] [Abstract][Full Text] [Related]
17. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
18. [Effect of AML1-ETO Fusion Protein on Transcriptional Regulation of p14
Zhuang WY; Li ZY; Chen YH; Liu Y; Chen ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):970-974. PubMed ID: 28823253
[TBL] [Abstract][Full Text] [Related]
19. [Complex translocation (8;15;21) (q22;p12;q22) in a child with AML-M2 showing de novo appearance of the short form of AML1-MTG8 chimeric mRNA during the course].
Watanabe A; Koike K; Fukushima T; Izumi I; Ohba K; Tsuchida M
Rinsho Ketsueki; 2001 Feb; 42(2):110-4. PubMed ID: 11280916
[TBL] [Abstract][Full Text] [Related]
20. The t(8;21) fusion protein contacts co-repressors and histone deacetylases to repress the transcription of the p14ARF tumor suppressor.
Hiebert SW; Reed-Inderbitzin EF; Amann J; Irvin B; Durst K; Linggi B
Blood Cells Mol Dis; 2003; 30(2):177-83. PubMed ID: 12732181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]